Financhill
Back

Royalty Pharma PLC Vs. Arrowhead Pharmaceuticals Industry Stock Comparison

Sell
31

RPRX
Royalty Pharma PLC

Last Price:
27.26
Seasonality Move:
-2.02%
Sell
24

ARWR
Arrowhead Pharmaceuticals

Last Price:
24.77
Seasonality Move:
3.98%
Sell
31
Royalty Pharma PLC (RPRX) is a Sell

Is Royalty Pharma PLC a Buy, Sell or Hold?

  • The current Royalty Pharma PLC [RPRX] share price is $27.27. The Score for RPRX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • RPRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
24
Arrowhead Pharmaceuticals (ARWR) is a Sell

Is Arrowhead Pharmaceuticals a Buy, Sell or Hold?

  • The current Arrowhead Pharmaceuticals [ARWR] share price is $24.77. The Score for ARWR is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • ARWR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RPRX Stock Price Chart

What is Royalty Pharma PLC's stock price today?

  • The Royalty Pharma PLC share price today is $27.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing selling pressure, which indicates risk of future bearish movement.

ARWR Stock Price Chart

What is Arrowhead Pharmaceuticals's stock price today?

  • The Arrowhead Pharmaceuticals share price today is $24.77
    The current trend is relatively stagnant and ARWR is experiencing selling pressure, which indicates risk of future bearish movement.

RPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 36.31 Sell
Chaikin Money Flow: -1694297 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.71 - 28.35) Sell
Bollinger Bands (100): (27.98 - 30.06) Sell

ARWR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 51.83 Buy
Chaikin Money Flow: -440729 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.48 - 24.7) Buy
Bollinger Bands (100): (24.81 - 33.69) Sell

RPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.98 Sell
20-day SMA: 28.07 Sell
50-day SMA: 28.92 Sell
200-day SMA: 28.57 Sell
8-day EMA: 27.92 Sell
20-day EMA: 28.15 Sell
50-day EMA: 28.59 Sell
200-day EMA: 29.61 Sell

ARWR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.98 Buy
20-day SMA: 23.73 Buy
50-day SMA: 25.57 Sell
200-day SMA: 28.21 Sell
8-day EMA: 24.19 Buy
20-day EMA: 24.16 Buy
50-day EMA: 25.62 Sell
200-day EMA: 28.8 Sell

Royalty Pharma PLC Earnings Growth & RPRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.19 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.20 per share, and an increase next year of $0.38 per share.

Arrowhead Pharmaceuticals Earnings Growth & ARWR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.03 per share, a decrease this year of $1.64 per share, and an increase next year of $0.20 per share.

Royalty Pharma PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arrowhead Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):